Chromocell Therapeutics Corporation (CHRO)
NYSEAMERICAN: CHRO · Real-Time Price · USD
0.659
+0.018 (2.81%)
Oct 30, 2024, 4:00 PM EDT - Market closed
Chromocell Therapeutics Employees
As of December 31, 2023, Chromocell Therapeutics had 8 total employees, including 4 full-time and 4 part-time employees. The number of employees increased by 6 or 300.00% compared to the previous year.
Employees
8
Change (1Y)
6
Growth (1Y)
300.00%
Revenue / Employee
n/a
Profits / Employee
-$1,224,354
Market Cap
3.80M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 8 | 6 | 300.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Molecular Templates | 62 |
| Sharps Technology | 57 |
| Theriva Biologics | 22 |
| Virpax Pharmaceuticals | 7 |
| Oragenics | 5 |
| Titan Pharmaceuticals | 4 |
| Avenue Therapeutics | 3 |
| Bone Biologics | 2 |
CHRO News
- 1 day ago - Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain - GlobeNewsWire
- 6 days ago - Chromocell Announces Amendment to Stock Repurchase Plan - GlobeNewsWire
- 6 weeks ago - Chromocell to Participate in Life Sciences Investor Forum September 19th - GlobeNewsWire
- 3 months ago - Chromocell Announces Stock Repurchase Plan - GlobeNewsWire
- 3 months ago - Chromocell to Participate in the Virtual Investor Lunch Break Series - GlobeNewsWire
- 6 months ago - Chromocell To Present at Alliance Global Partner's Healthcare Company Showcase on Tuesday, May 21, 2024 - GlobeNewsWire
- 7 months ago - Chromocell Issues Letter to Stockholders from Chief Executive Officer - GlobeNewsWire
- 7 months ago - Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler - GlobeNewsWire